Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
arachidonic acid/põletik
Link salvestatakse lõikelauale
Leht 1 alates 78 tulemused
Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
The present invention relates to the use of saturated monocyclic or bicyclic terpenes for the treatment of inflammatory diseases. It is particularly concerned with the use of saturated monocyclic terpenes for the treatment of steroid-requiring inflammatory diseases
Interdigitation-fusion liposomes containing arachidonic acid metabolites
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Arachidonic acid, and other twenty carbon "essential" fatty acids having at least three double bonds, can be used to make prostaglandins (for a review, see, e.g., Goodman and Gilman's The Pharmacological Basis of Therapeutics (A. Goodman Gilman et al., eds.), Pergamon Press, New York (1990), pp.
Dietary control of arachidonic acid metabolism
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates generally to the fields of lipid metabolism and dietary supplementation. More particularly, it concerns compositions and methods for controlling or reducing symptoms of inflammation or inflammatory conditions that include the use of unsaturated
Inhibitors of arachidonic acid formation
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD
The invention relates to compositions and methods for treating, moderating, and preventing inflammation. Specifically, the invention relates to compositions useful for inhibiting the formation of arachidonic acid, which is a precursor of pro-inflammatory eicosanoids. The invention also relates
Dietary control of arachidonic acid metabolism
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the fields of lipid metabolism and dietary supplementation. More particularly, it concerns compositions and methods for inhibiting an increase in serum arachidonic acid of a mammal to which
Inhibition of inflammatory lipid mediators
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The invention relates to the area of inflammatory mediators. The invention is based on the discovery that blocking a key enzyme responsible for arachidonate movement (or remodelling), Coenzyme A-independent transacylase (CoA-IT), inhibits the production of lipid mediators
Methods for detecting inflammatory bowel disease in a feline
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to compositions and methods for preventing or treating inflammatory bowel disease and particularly to the use of docosahexaenoic acid for preventing or treating feline inflammatory bowel disease.
2. Description of
Method for preparing compositions for preventing or treating inflammatory bowel disease
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to compositions and methods for presenting or treating inflammatory bowel disease and particularly to the use of docosahexaenoic acid for preventing or treating feline inflammatory bowel disease.
2. Description of
Treatment using arachidonic acid metabolite and particulate formulations
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Arachidonic acid, and other twenty carbon "essential" fatty acids having at least three double bonds, can be used to make prostaglandins (for a review, see, e.g., Goodman and Gilman's The Pharmacological Basis of Therapeutics (A. Goodman Gilman et al., eds.), Pergamon Press, New York (1990), pp.
Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SEQUENCE LISTING
This application includes a Sequence Listing submitted electronically as a text file named "17738US_sequencelisting.txt," created on Nov. 5, 2010, with a size of 42 kb. The sequence listing consists of 43 sequences and is incorporated by reference.
FIELD OF INVENTION
The invention
Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF INVENTION
The invention relates generally to accelerating or enhancing bone formation or fracture healing by modulating an arachidonic acid metabolic or signaling pathway, in particular by using inhibitors of 5-lipoxygenase activity.
BACKGROUND OF THE INVENTION
Bone fractures are a common
Chemical entities with multiple modes of anti-inflammatory action
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND INFORMATION
The present invention relates to the multiple modes of inhibition by a drug molecule of an enzymatic pathway postulated for a disease state. In particular the invention relates to new chemical compounds that inhibit the various enzymes in the arachidonic acid pathway
Use of 3-(arylmethyleneamino)-1-aryl-2-pyrazolines in the prophylaxis and treatment of inflammation, pain, pyresis, and asthma
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
This invention relates to heterocyclic compounds and their preparation and to the use of such compounds of pharmaceutical formulations thereof in medicine in a mammal, including man, as e.g. anti-inflammatory or anti-allergic agents or as agents in the prevention of tissue rejection.
Accordingly,
Arachidonic acid releasing phospholipase A2 enzyme and methods of use
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention relates to novel DNA and peptide sequences encoding a family of phospholipase A.sub.2 enzymes, which are useful in methods for detecting the anti-inflammatory potential of various chemical agents. The invention also details methods for making the novel peptides, and methods for
Non-steroidal anti-inflammatory agent therapy for epithelial cell cancer
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention relates to methods and compositions that provide for the diagnosis and treatment of prostatic intraepithelial neoplasia. A particular aspect of the invention relates to methods and compositions containing compounds which inhibit phospholipase A.sub.2, particularly those that
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
